Ex_FW
vivo_FW
activation_NN
of_IN
tumor-draining_JJ
lymph_NN
node_NN
T_NN
cells_NNS
reverses_VBZ
defects_NNS
in_IN
signal_NN
transduction_NN
molecules_NNS
._.

The_DT
adoptive_JJ
transfer_NN
of_IN
tumor-draining_JJ
lymph_NN
node_NN
-LRB-_-LRB-
LN_NN
-RRB-_-RRB-
T_NN
cells_NNS
activated_VBN
ex_FW
vivo_FW
with_IN
anti-CD3_NN
and_CC
interleukin_NN
2_CD
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
mediates_VBZ
the_DT
regression_NN
of_IN
the_DT
poorly_RB
immunogenic_JJ
murine_JJ
melanoma_NN
D5_NN
._.

The_DT
efficacy_NN
of_IN
the_DT
activated_VBN
LN_NN
cells_NNS
is_VBZ
augmented_VBN
when_WRB
the_DT
sensitizing_VBG
tumor_NN
is_VBZ
a_DT
genetically_RB
modified_VBN
variant_NN
-LRB-_-LRB-
designated_VBN
D5G6_NN
-RRB-_-RRB-
that_WDT
secretes_VBZ
granulocyte\/macrophage-colony-stimulating_JJ
factor_NN
._.

In_IN
contrast_NN
to_TO
anti-CD3_JJ
\/_JJ
IL-2-activated_JJ
LN_NN
cells_NNS
,_,
adoptive_JJ
transfer_NN
of_IN
freshly_RB
isolated_VBN
tumor-draining_JJ
LN_NN
T_NN
cells_NNS
has_VBZ
no_DT
therapeutic_JJ
activity_NN
._.

To_TO
determine_VB
whether_IN
the_DT
acquisition_NN
of_IN
antitumor_JJ
function_NN
during_IN
ex_FW
vivo_FW
activation_NN
is_VBZ
associated_VBN
with_IN
modifications_NNS
in_IN
signal_NN
transduction_NN
capacity_NN
,_,
the_DT
protein_NN
tyrosine_NN
kinases_NNS
p56lck_NN
and_CC
p59fyn_NN
and_CC
proteins_NNS
of_IN
the_DT
NF-kappaB_NN
family_NN
were_VBD
analyzed_VBN
in_IN
tumor-draining_JJ
LN_NN
T_NN
cells_NNS
._.

The_DT
levels_NNS
of_IN
p56lck_NN
and_CC
p59fyn_NN
were_VBD
lower_JJR
in_IN
tumor-draining_JJ
than_IN
in_IN
normal_JJ
LN_NN
T_NN
cells_NNS
and_CC
production_NN
of_IN
tyrosine-phosphorylated_JJ
substrates_NNS
was_VBD
markedly_RB
depressed_VBN
following_VBG
anti-CD3_JJ
stimulation_NN
._.

After_IN
5-day_JJ
anti-CD3_NN
\/_:
IL-2_NN
activation_NN
,_,
levels_NNS
of_IN
p56lck_NN
and_CC
p59fyn_NN
and_CC
protein_NN
tyrosine_NN
kinase_NN
activity_NN
increased_VBD
._.

Interestingly_RB
,_,
the_DT
levels_NNS
of_IN
p56lck_NN
,_,
p59fyn_NN
,_,
and_CC
tyrosine_NN
kinase_NN
activity_NN
were_VBD
higher_JJR
in_IN
activated_VBN
T_NN
cells_NNS
derived_VBN
from_IN
LN_NN
that_WDT
drained_VBD
D5G6_NN
than_IN
they_PRP
were_VBD
in_IN
those_DT
from_IN
D5_NN
tumors_NNS
._.

In_IN
contrast_NN
,_,
the_DT
cytoplasmic_JJ
levels_NNS
of_IN
c-Rel_NN
and_CC
Rel_NN
A_NN
were_VBD
normal_JJ
in_IN
freshly_RB
isolated_VBN
tumor-draining_JJ
LN_NN
,_,
as_IN
was_VBD
nuclear_JJ
kappaB_NN
DNA-binding_JJ
activity_NN
induced_VBN
by_IN
anti-CD3_JJ
mAb_NN
or_CC
phorbol_NN
myristate_NN
acetate_NN
._.

Stimulation_NN
of_IN
activated_VBN
LN_NN
cells_NNS
with_IN
D5_NN
tumor_NN
cells_NNS
induced_VBD
the_DT
nuclear_JJ
translocation_NN
of_IN
NF-kappaB_NN
._.

These_DT
findings_NNS
indicate_VBP
that_IN
the_DT
recovery_NN
of_IN
proteins_NNS
mediating_VBG
signal_NN
transduction_NN
through_IN
the_DT
T_NN
cell_NN
receptor\/CD3_NN
complex_NN
in_IN
LN_NN
T_NN
cells_NNS
activated_VBN
ex_FW
vivo_FW
was_VBD
associated_VBN
with_IN
the_DT
acquisition_NN
of_IN
antitumor_JJ
function_NN
._.

